News
Investment bank Lazard surpassed second-quarter profit estimates on Thursday, as a rebound in dealmaking helped power record ...
AstraZeneca said on Thursday its experimental therapy, gefurulimab, met the primary goal and all secondary endpoints in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback